Research
Current Research Focus: Type 1 Diabetes
Since 2019, I have pivoted my entire research portfolio to Type 1 Diabetes technology. This transformative shift has resulted in:
Research Infrastructure
- Multidisciplinary Team: Partnerships across NHS, Diabetes UK, FBMH, and Manchester Diabetes Institute
- PhD Training: 10 PhD researchers working on diabetes technology
- Citizen Science: Brains Trust of 80 citizen scientists with Type 1 Diabetes
- Clinical Network: Diabetes and Hypoglycaemia Technology Network (Pankhurst)
Research Translation
Melontech Start-up: Currently in stage 3 with UoM Innovation Factory, securing early funding for initial pilots to enable faster pipeline from research to practice.
Grant Success
Recent translation and development grants:
- EPSRC Healthcare Grant (~£850k) - Under review
- MRC/Wellcome Trust Confidence 4 Translation (£65k) - 2023/2024
- Pankhurst Seedcorn Funding (£15k) - 2024
- MRC Translation Grant (£25k) - 2023/24
- Wellcome Trust Translation Grant (£25k) - 2022/23
- Melontech Startup Seedcorn (£20k) - 2022
Research Output
11 journal papers in high-impact diabetes and hypoglycaemia venues, addressing critical challenges in hypoglycaemia prediction and management.
Research Areas
Digital Phenotyping & Personalisation
Developing adaptive user models for extreme users and extreme environments, focusing on:
- Continuous glucose monitoring and hypoglycaemia prediction
- Smartphone-based behavioural sensing
- Wearable technology for health monitoring
- Digital biomarkers for chronic conditions
Web Accessibility
Over 20 years establishing Web Accessibility as a respected scientific research discipline through:
- Conference creation and organisation
- Journal editing and standards participation
- Raising standards in empiricism and open access
- International standards development (W3C)
Ambient Intelligence & User Modelling
Research in ambient intelligence systems that adapt to user behaviour and context:
- Activity prediction in smart environments
- Behaviour change interventions
- Intrinsic motivation recognition
- Social sensing with smartphones
Health Technology Applications
- Type 1 Diabetes: Hypoglycaemia reduction technology
- Parkinson’s Disease: Day-to-day monitoring and social behaviour tracking
- Visual Impairment: Web accessibility and adaptive interfaces
- Neuro-Divergence: Eye-tracking for autism detection
- COVID-19: Digital phenotypes for policy compliance
Collaborative Research
Industry Partnerships
Current and past collaborations include:
- Healthcare: NHS, Diabetes UK, Novonordisk, Eli Lilly, Philips Healthcare
- Technology: BBC R&D, Google, Intel, IBM Research
- Engineering: Ove Arup Partners
- Telecommunications: Telefónica, DoCoMo
International Collaborations
- Finland: Academy of Finland ICT 2023 programme with University of Oulu
- USA: Carnegie Mellon University
- Spain: University of the Basque Country, CTIC
- Japan: IBM Tokyo Research Laboratory
Research Impact
Metrics
- Publications: 160+ papers
- Citations: 6,014
- h-index: 44
- i10-index: 129
- Downloads: 47,131 cumulative (ACM Bibliometrics)
Rankings
- Top 5% internationally for HCI and WWW (Google Scholar, Microsoft Research)
- 98th internationally for HCI using career and domain normalised hs-index (Scholarometer)
Recognition
ACM President Alexander Wolf described my work as having “singular impacts on the vital field of computing” with “achievements that have had a significant influence on the social, economic and cultural areas of daily lives all over the world.”
Commended as “instrumental to the development of the Web” by Sir Tim Berners-Lee.
Research Facilities
Interaction Analysis and Modelling Laboratory (IAM)
Established and equipped through competitive bids, IAM comprises:
- Two-room Usability Suite
- Three Eye-trackers
- Three Galvanic Skin Response monitors
- Full Audio/Visual recording systems
- Facilities for external companies (BBC, Thomson Reuters, NICE)
The laboratory brings together a multidisciplinary team of Human Factors specialists, Psychologists, and Computer Scientists, with an international network of IAM laboratories developing across Europe.